Combinations or Single Agents, Crossover or No Crossover: Considering Chemotherapy Strategies in the Multi-Chaptered Story of Metastatic Breast Cancer
Nov. 14, 2011
This podcast will critically review randomized phase III trial data examining the relative role of taxane
monotherapy versus combination therapy as first-line treatment for HER2-negative metastatic breast
cancer.